Nevirapine 100mg disp. tabs/PAC-60

NOTE: The description below is for a standard product. It is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: supply@unicef.org

General Description:
Nevirapine 100mg dispersible tablets, bottle pack of 60

Technical Specifications:
Each dispersible tablet contains Nevirapine 100mg calculated on the anhydrous basis.
Tablets should be scored with at least one break line to allow for division of tablets into two parts, each containing the same amount of active ingredient
The tablets are used to prepare an oral suspension.

Therapeutic class:
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)

Standard shelf life:
24 Months

Other available formulations:
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use:
For more details, please click the links listed below:

WHO treatment guidelines


and

WHO Essential Medicines Library


or your regional national guidelines

For details about paediatric dosage schemes, please click the links listed below:

WHO HIV/AIDS


WHO Generic tool for assessing paediatric ARV dosing


Indications:
Management of HIV infection in combination with at least two other antiretroviral drugs. By mouth (oral), PO.
Prevention of mother-to-child transmission in HIV-infected patients

Storage:
Do not store above 30ºC (86ºF).
Store in a tightly closed container
Keep out of reach and sight of children.

Dispensing instructions:
Dispense in original container. Do not repack
Tablets are to be dispersed in about 5ml water immediately before administration

Regulatory Status:
For latest updates, please click the links listed below:

List of WHO Prequalified Medicines


List of USFDA approved and tentatively approved items